This paper provides an outline of the development and growth of EUROCAT, the European network of congenital anomaly registers. In recent years the network has been through a period of transition and change. The Central Register of data has transferred from the Ulster University to the EU Joint-Research-Centre, Ispra, Italy.The benefits of combining data from across Europe, from different populations and countries are described by the uses to which these data can be put. These uses include:. surveillance of anomalies at a local, regional or pan-European level. pharmacovigilance. registration of rare diseasesNew studies and projects are underway, including EUROlinkCAT (a Horizon 2020 funded data-linkage project), promising a fruitful future in further research of congenital anomalies.
Tucker, D., Morris, J., Neville, A., Garne, E., Agnieszka, K-O., Monica, L., Loane, M., Martin, S., Nicholl, C., Rankin, J., & Rissmann, A. (2018). EUROCAT: an update on its functions and activities. Journal of Community Genetics, 1-4. https://doi.org/10.1007/s12687-018-0367-3